Chemotherapy Induced Oral Mucositis Market: How Is Palifermin Efficacy Creating Biological Prevention Paradigm?
Palifermin efficacy creating biological prevention — palifermin (Kepivance) — a human keratinocyte growth factor (KGF) recombinant protein — demonstrating efficacy in reducing severe oral mucositis incidence in HSCT patients when administered perioperatively, establishing biological growth factor replacement as a mechanistic approach to OM prevention distinct from symptomatic...
0 التعليقات 0 المشاركات 21 مشاهدة 0 معاينة